Expression of purinergic P 2 X 2-receptors in neurogenic bladder dysfunction due to spinal cord injury: A preliminary immunohistochemical study

Spinal Cord

Volumn 47, Issue 7, 2009, Pages 561-564

  Pannek, J ^a,c   Janek, S ^a   Sommerer, F ^b   Tannapfel, A ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c SWISS PARAPLEGIC RESEARCH   (Switzerland)

Author keywords

Innervation; Neurogenic lower urinary tract dysfunction; Purinergic receptors; Spinal cord injury

Indexed keywords

PURINERGIC P2X2 RECEPTOR; PURINERGIC P2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; DETRUSOR MUSCLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; URINE RETENTION; UROTHELIUM; BLADDER; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PILOT STUDY; SKELETAL MUSCLE;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PILOT PROJECTS; RECEPTORS, PURINERGIC P2; SPINAL CORD INJURIES; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; UROTHELIUM; YOUNG ADULT;

EID: 67651148121     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2008.165     Document Type: Article

References (19)

1. de Groat WC, Kawatani M, Hisamitsu T, Cheng CL, Ma CP, Thor K et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; 30 (Suppl): 71-77.
2. Gerridzen RG, Thijssen AM, Dehoux E. Risk factors for upper tract deterioration in chronic spinal cord injured patients. J Urol 1992; 147: 416-418.
3. Perkash I. Long-term urologic management of the patient with spinal cord injury. Urol Clin North Am 1993; 20: 423-434.
4. Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007; 26: 228-233.
5. Inoue R, Brading AF. Human, pig and guinea-pig bladder smooth muscle cells generate similar inward currents in response to purinoceptor activation. Br J Pharmacol 1991; 103: 1840-1841.
6. Rapp DE, Lyon MB, Bales GT, Cook SP. A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 2005; 48: 303-308.
7. Tempest HV, Dixon AK, Turner WH, Elneil S, Sellers LA, Ferguson DR. P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 2004; 93: 1344-1348.
8. O'Reilly BA, Kosaka AH, Knight GF, Chang K, Ford APDW, Rymer JM et al. P2X receptors and their role in female idiopathic detrusor instability. J Urol 2002; 167: 157-164.
9. Moore KH, Ray FR, Barden JA. Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence. J Neurosci 2001; 21: 17-22.
10. Harvey RA, Skennerton DE, Newgreen D, Fry CH. The contractile potency of adenosine triphosphate and ecto-adenosinetripho-sphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J Urol 2002; 168: 1235-1239.
11. Brady CM, Apostolidis A, Yiangou Y, Baecker PA, Ford AP, Freeman A et al. P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 2004; 46: 247-253.
12. Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005; 174: 977-982.
13. Bayliss M, Wu C, Newgreen D, Mundy AR, Fry CH. A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 1999; 162: 1833-1839.
14. O'Reilly BA, Kosaka AH, Chang TK, Ford AP, Popert R, Rymer JM et al. A quantitative analysis of purinoceptor expression in human fetal and adult bladders. J Urol 2001; 165: 1730-1734.
15. O'Reilly BA, Kosaka AH, Chang TK, Ford AP, Popert R, McMahon SB. A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction. BJU Int 2001; 87: 617-622.
16. Ford APDW, Gever JR, Nunn PA, Zhong Y, Cefalu JS, Dillon MP et al. Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol 2006; 147: S132-S143.
17. Lee HY, Bardini M, Burnstock G. Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol 2000; 163: 2002-2007.
18. Radley SC, Rosario DJ, Chapple CR, Farkas AG. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol 2001; 166: 2253-2258.
19. Lu SH, Groat WC, Lin AT, Chen KK, Chang LS. Evaluation of purinergic mechanism for the treatment of voiding dysfunction: a study in conscious spinal cord-injured rats. J Chin Med Assoc 2007; 70: 439-444.